Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice

被引：0
作者：
Douglas M. McCarty
Julianne DiRosario
Kadra Gulaid
Smruti Killedar
Arie Oosterhof
Toin H. van Kuppevelt
Paul T. Martin
Haiyan Fu
机构：
[1] The Ohio State University,The Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital
[2] The Ohio State University,Department of Pediatrics, College of Medicine and Public Health
[3] Radboud University Nijmegen Medical Center,Department of Biochemistry, Nijmegen Center for Molecular Life Sciences
来源：
Metabolic Brain Disease | 2011年 / 26卷
关键词：
MPS IIIB; Lysosomal storage disease; Heparan sulfate; Neuropathology; Glycobiosynthesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The primary pathology in mucopolysaccharidosis (MPS) IIIB is lysosomal storage of heparan sulfate (HS) glycosaminoglycans, leading to complex neuropathology and dysfunction, for which the detailed mechanisms remain unclear. Using antibodies that recognize specific HS glycoforms, we demonstrate differential cell-specific and domain-specific lysosomal HS-GAG distribution in MPS IIIB mouse brain. We also describe a novel neuron-specific brain HS epitope with broad, non-specific increase in the expression in all neurons in MPS IIIB mouse brain, including cerebellar granule neurons, which do not exhibit lysosomal storage pathology. This suggests that biosynthesis of certain HS glycoforms is enhanced throughout the CNS of MPS IIIB mice. Such a conclusion is further supported by demonstration of increased expression of multiple genes encoding enzymes essential in HS biosynthesis, including HS sulfotransferases and epimerases, as well as FGFs, for which HS serves as a co-receptor, in MPS IIIB brain. These data suggest that lysosomal storage of HS may lead to the increase in HS biosyntheses, which may contribute to the neuropathology of MPS IIIB by exacerbating the lysosomal HS storage.
引用
收藏
页码：9 / 19
页数：10
相关论文
共 290 条
  • [1] Abramoff MD(2004)Image processing with image J Biophotonics Int 11 36-42
  • [2] Magelhaes PJ(2007)New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy Hum Genet 121 1-22
  • [3] Ram SJ(2007)A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease J Neurosci 27 9928-9940
  • [4] Beck M(2004)Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum J Neurosci 24 10229-10239
  • [5] Cearley CN(2002)Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies J Biol Chem 277 10982-10986
  • [6] Wolfe JH(2004)Prevention of neuropathology in the mouse model of Hurler syndrome Ann Neurol 56 68-76
  • [7] Cressant A(2009)Innate and adaptive immune activation in the brain of MPS IIIB mouse model J Neurosci Res 87 978-990
  • [8] Desmaris N(2010)Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease Eur J Hum Genet 18 200-205
  • [9] Verot L(2002)Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu Rev Biochem 71 435-471
  • [10] Brejot T(2002)Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery Mol Ther 5 42-49
12345678910